Dr. Susanne Ruth Dillon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1363 W Spruce Ave, Wasilla, AK 99654 Phone: 907-376-2411 Fax: 907-352-3301 |
Valerie K Krozel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 E Bogard Rd Ste 233, Wasilla, AK 99654 Phone: 907-352-1300 Fax: 907-352-1310 |
Mrs. Patricia Gail Johnson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 E Bogard Rd, Wasilla, AK 99654 Phone: 907-373-2225 Fax: 907-376-9225 |
Dr. Joyce Camille Restad, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5461 Mayflower, #4, Wasilla, AK 99654 Phone: 907-376-4644 Fax: 907-376-4690 |
Dr. Jaron Miner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 S Knik Goose Bay Rd, Wasilla, AK 99654 Phone: 801-360-1089 |
Dr. Ray Don Kelley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3066 E Meridian Park Loop, Wasilla, AK 99654 Phone: 907-357-9590 |
Frank Adam Greathouse, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Bogard Rd Ste 100, Building A, Wasilla, AK 99654 Phone: 907-352-6200 Fax: 907-373-0725 |
Dr. Jessica J Jachimiec, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3066 E Meridian Park Loop, Wasilla, AK 99654 Phone: 907-357-9590 |
Dr. Lisa L Harrison, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 E Westpoint Dr, Suite 310, Wasilla, AK 99654 Phone: 907-373-9453 Fax: 907-373-9457 |
News Archive
Researchers from Mayo Clinic have discovered that allergic rhinitis is associated with the development of Parkinson's disease later in life. Findings will be published in the Aug. 8 issue of the journal Neurology.
Antibodies are now established as therapeutics and indispensable in the research lab. In con-trast to high-quality therapeutics, commercial antibodies used in research often do not proper-ly function, as an international group of authors around Andreas Plückthun of UZH have warned.
Bristol-Myers Squibb and Medivir AB have announced a worldwide collaboration to develop and commercialize MIV-170, a preclinical non-nucleoside reverse transcriptase inhibitor, or NNRTI, intended for the treatment of HIV-1 infection in adults as part of an antiretroviral drug regimen.
Health Care Compliance Strategies, Inc. (HCCS) announced today that it will celebrate National Health Care Compliance Training Week, October 26th through November 1st, by providing free unlimited access to the HCCS Infection Control multimedia online training course and a special Expert Webinar on preventing Identity Theft in healthcare organizations.
Air pollution could be putting patients with heart disease at risk by affecting blood vessels and clotting, researchers warn
› Verified 2 days ago